Targeting PCOS-related inflammation with bioactive compounds of Syzygium polyanthum (Wight) Walp. leaves extract: An in silico study
Journal of Pharmacy & Pharmacognosy Research · 01.03.2026 · 14 (2) · 2525
DOI: 10.56499/jppres_14.2.2525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.03.2026. Verfasst von Renny Aditya und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Context
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting reproductive-aged women, often associated with chronic inflammation. The search for novel therapeutic agents has led to the exploration of natural compounds with anti-inflammatory properties. Syzygium polyanthum, commonly known as Indonesian bay leaf, is traditionally used in herbal medicine and contains bioactive compounds with potential pharmacological effects.
Aims
To investigate, through in silico approaches, the molecular interactions between selected compounds from S. polyanthum and inflammatory target proteins relevant to polycystic ovary syndrome therapy.
Methods
Molecular docking analysis was performed using AutoDock Vina integrated with PyRx version 0.8. Additionally, absorption, distribution, metabolism, and excretion (ADME) analysis was conducted to evaluate the pharmacokinetic properties of the selected compounds. The binding affinities of the ligands were evaluated against key inflammatory proteins, namely MMP-9, IL6ST, and HIF-1.
Results
The results suggest that nootkatone exhibits strong binding interactions with inflammatory mediators, indicating its promising potential due to its stable binding affinity in all protein targets (-6.8 kcal/mol in MMP-9; -6.5 kcal/mol in IL6ST; and -7.1 kcal/mol in HIF-1) and favorable pharmacokinetic properties as revealed by ADME analysis, supporting its potential as an anti-inflammatory agents for PCOS management.
Conclusions
These findings suggest that nootkatone may serve as a promising natural anti-inflammatory candidate for the management of polycystic ovary syndrome. Further studies employing molecular dynamics analyses, as well as in vitro and in vivo experiments, are warranted to validate these results.
Zitieren
APA
Aditya, R., & Nafisah, W. (2026). Targeting PCOS-related inflammation with bioactive compounds of Syzygium polyanthum (Wight) Walp. leaves extract: An in silico study. Journal of Pharmacy & Pharmacognosy Research, 14(2), 2525. https://doi.org/10.56499/jppres_14.2.2525
Vancouver
Aditya R, Nafisah W. Targeting PCOS-related inflammation with bioactive compounds of Syzygium polyanthum (Wight) Walp. leaves extract: An in silico study. Journal of Pharmacy & Pharmacognosy Research. 2026;14(2):2525. doi:10.56499/jppres_14.2.2525
BibTeX
@article{Aditya2026,
author = {Aditya, Renny and Nafisah, Wirdatun},
title = {Targeting PCOS-related inflammation with bioactive compounds of Syzygium polyanthum (Wight) Walp. leaves extract: An in silico study},
journal = {Journal of Pharmacy & Pharmacognosy Research},
year = {2026},
volume = {14},
number = {2},
pages = {2525},
doi = {10.56499/jppres_14.2.2525}
}
EUVIMED